Cited by 19Social Media in Health EducationHealth Literacy and Information AccessibilityPelvic floor disorders treatments

Media coverage of the 2019 United States Food and Drug Administration ordered withdrawal of vaginal mesh products for pelvic organ prolapse

Shoureshi, Poone S., Lee, Wai, Kobashi, Kathleen C., Sajadi, Kamran P.·2021·International Urogynecology Journal

Abstract

Introduction and hypothesis On April 16, 2019, the United States Food and Drug Administration announced a withdrawal on sales and distribution of transvaginal mesh products for pelvic organ prolapse. The aim of this study was to asses online user behavior on pelvic-mesh related articles after the withdrawal and to evaluate article accuracy. Materials and methods We used Google Trends© to identify the terms related to pelvic mesh that experienced increased activity after the FDA announcement. The terms were analyzed for worldwide social media engagement (Facebook, Twitter, Pinterest, and Reddit) between April 16-19, 2019. The top ten lay press articles shared for each term were evaluated. We also examined the top ten Google search results for each term on June 6, 2019, in the US to evaluate what information was available after peak interest subsided. Results During peak activity in April, 30 unique articles were identified after the FDA announcement. Two (6.7%) did not mention the April 2019 FDA announcement. Seven (23%) discussed mesh for stress urinary incontinence. After peak interest on June 6, 2019, Google identified 26 unique articles for the four terms. Seven (27%) did not mention the FDA announcement, and 3 (12%) mentioned mesh for incontinence. Conclusions Internet search patterns and social media behavior following the April 2019 ordered withdrawal on transvaginal mesh for pelvic organ prolapse reveal that some of the most disseminated information did not accurately…

Integrity signals

Registry

Crossref · 10.1007/s00192-020-04401-6

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The FDA has raised concerns about the safety and effectiveness of PP meshes, leading to reclassification as high-risk Class III and withdrawal of certain products from the market.

    “Notably, the U.S. Food and Drug Administration (FDA) has raised concerns regarding the safety and effectiveness of PP meshes, leading to the reclassification of these devices as high-risk (Class III) and the subsequent withdrawal of certain products from the market [249,250].”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Shoureshi, P. S., Lee, W., Kobashi, K. C., & Sajadi, K. P.
Affiliations
  • Oregon Health & Science University (US)
  • Virginia Mason Medical Center (US)
Corresponding author
Shoureshi, Poone S.
Venue
International Urogynecology Journal
Published
2020-06-29
Volume
32
Issue
2
Pages
375-379
ISSN
  • 0937-3462 (ISSN-L)
  • 1433-3023
OpenAlex
W3038426491
Cited by
19
References
3
Citations by year
2026: 1 · 2025: 4 · 2024: 2 · 2023: 2 · 2022: 1 · 2021: 8 · 2020: 1
FWCI
1.59
Type
journal article
Language
en
Open access
closed
Locations
  • International Urogynecology Journal (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Social Sciences › Health › Social Media in Health Education
  • Health Sciences › Health Professions › General Health Professions › Health Literacy and Information Accessibility
  • Health Sciences › Medicine › Rheumatology › Pelvic floor disorders treatments
Keywords
transvaginal mesh, pelvic organ prolapse, media coverage, social media engagement, Google Trends, online search behavior, information accuracy, female pelvic medicine, reconstructive surgery
MeSH terms
Female, Humans, Surgical Mesh, United States, United States Food and Drug Administration, Urinary Incontinence, Urinary Incontinence, Stress, Pelvic Organ Prolapse

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review